Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial.
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2014
At a glance
- Drugs Cyclobenzaprine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 24 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 17 May 2013 Planned end date changed from 1 Dec 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 12 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.